Experience

Molecular Partners

• Switzerland
• Biotechnology Research
• 100 - 200 Employee

• SVP Biology

  • Sep 2022 - Present

  Zurich, Switzerland Head of the Biology department, leading Molecular Partners discovery and early development effort. Participate to the definition of Molecular Partners strategy and portfolio management. Member of the leadership team

• VP Biology

  • Sep 2020 - Sep 2022

  Build the Biology department, covering from pre-clinical science to translational medicine. Lead all biology-related activities, from target identification to clinical trials. Participate to the definition of Molecular Partners strategy and portfolio management. Member of the leadership team



Alesta Therapeutics

• Netherlands
• Biotechnology Research
• 1 - 100 Employee

• CSO

  • Sep 2018 - Sep 2020

  Stevenage, United Kingdom Cofounded Blackbelt Therapeutics. Defined and implemented Black Belt Therapeutics strategy for immuno-oncology discovery, preclinical development and translational science, ensuring that Black Belt Therapeutics remains on the cutting edge of this fast moving field.



Tusk Therapeutics

• VP Immunology

  • Jan 2015 - Sep 2018

  London, United Kingdom Provided scientific leadership to define and implement Tusk strategy for immuno-oncology discovery, preclinical development and translational science, ensuring that Tusk Therapeutics remains on the cutting edge of this fast-moving field. Key achievement: Led the effort to take the anti-CD25 antibody from early academic research to a successful pre-IND stage project, leading to a successful exit, Tusk Therapeutics being acquired by Roche Pharmaceuticals in Sept 2018



Droia Ventures

• Belgium
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Lead Project Manager

  • Nov 2012 - Dec 2014

  Melbourne, Australia Mandated by DROIA to manage locally a Melbourne-based start-up company, developing cancer vaccines



Genticel

• Senior Director Immunology

  • Aug 2010 - Nov 2012

  Toulouse Area, France Leading the pre-clinical and clinical pharmacology activities, successful implementation of a phase I trial for the lead therapeutic vaccine candidate in HPV patients and smooth transition to phase II. Support fundraising and partnering effort with successful financing of the phase I and then phase II trial.



Merial

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of the immunomodulation platform

  • Jan 2008 - Aug 2010

  Head of the adjuvants and Immunomodulation research platform: Leading a team of dedicated experts aiming at anticipating strategic needs for Merial by identifying, evaluating and selecting new adjuvants and immunomodulators for the development of new biological products. This include internal development of new formulations as well as selection of appropriate partnership for futur adjuvants acquisitions

• Head of the immunology laboratory

  • Sep 2007 - Aug 2010

  Head of the immunology laboratory: management of a team of 2 engineers and 4 technicians. Actively participating and providing its technical and scientific expertise to the R&D project teams, providing innovative solutions to improve Merial vaccines value for the market, actively participate to the recognition of Merial as a high scientific value and innovative enterprise by representing Merial during veterinarian and scientific meetings and via peer review publications, Building an… Show more Head of the immunology laboratory: management of a team of 2 engineers and 4 technicians. Actively participating and providing its technical and scientific expertise to the R&D project teams, providing innovative solutions to improve Merial vaccines value for the market, actively participate to the recognition of Merial as a high scientific value and innovative enterprise by representing Merial during veterinarian and scientific meetings and via peer review publications, Building an external network of partners within the local (Biopole), national and international scientific communauty in order to improve internal scientific and technical immunological expertise

• Veterinary Immunologist

  • Nov 2006 - Sep 2007

  Management of the immunology laboratory. Immunological follow up of research project, product support project. internal and external communication on veterinary species immune response. Evaluation of immunomodulators

• Veterinary clinician

  • Mar 2006 - Oct 2006

  Management of clinical studies



Centre équestre Genas

• Co-director and co-founder

  • 2002 - 2006

  Managing the herd keeping the account Relation with clients Teaching